Does cannabis affect cognitive functioning in patients with schizophrenia?
- PMID: 38196922
- PMCID: PMC10772380
- DOI: 10.1016/j.scog.2023.100299
Does cannabis affect cognitive functioning in patients with schizophrenia?
Abstract
Introduction: Cannabis use impairs cognitive performance in healthy subjects; several studies have shown improved cognitive outcomes in schizophrenic patients using cannabis. The aim of this study was to evaluate the effects of cannabis use on cognitive function in Moroccan patients with schizophrenia who were cannabis users.
Method: Two groups were recruited in a Moroccan University Psychiatric Centre. Fifty patients diagnosed with schizophrenia according to the DSM-V who were cannabis users (SZ CANN +) and forty-nine patients diagnosed with schizophrenia according to DSM-V who do not use cannabis (SZ CANN-). Cognitive functioning was assessed using the CogState neuropsychological battery.
Results: The results of the study suggest that SZ CANN- patients performed better in the test of psychomotor function, attention and verbal memory. While SZ CANN+ patients performed better in the test of working memory, visual memory and emotional recognition. We found no relationship between SZ CANN+ patients and SZ CANN- patients concerning executive function.
Conclusions: Our results suggest that cannabis use may have different effects on neurocognitive functioning. It is associated with disorders of psychomotor function, attention and verbal memory. So, it is associated with an improvement in working memory, visual memory and emotion recognition.
Keywords: Battery cognitive; Cannabis; Cognitive performance; Psychiatric disorders; Schizophrenia.
© 2023 Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Meta-analysis of neurocognition in young psychosis patients with current cannabis use.J Psychiatr Res. 2018 Apr;99:22-32. doi: 10.1016/j.jpsychires.2018.01.010. Epub 2018 Feb 3. J Psychiatr Res. 2018. PMID: 29407284
-
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.Schizophr Bull. 2012 Mar;38(2):316-30. doi: 10.1093/schbul/sbq079. Epub 2010 Jul 25. Schizophr Bull. 2012. PMID: 20660494 Free PMC article.
-
[Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].Psychiatriki. 2011 Jul-Sep;22(3):195-206. Psychiatriki. 2011. PMID: 21971195 Greek, Modern.
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
Neurocognitive functioning and cannabis use in schizophrenia.Curr Pharm Des. 2012;18(32):4999-5007. doi: 10.2174/138161212802884799. Curr Pharm Des. 2012. PMID: 22716156 Review.
Cited by
-
Exposotypes in psychotic disorders.Sci Rep. 2025 Aug 8;15(1):29003. doi: 10.1038/s41598-025-14438-6. Sci Rep. 2025. PMID: 40781464 Free PMC article.
-
Letter to the editor: "Associative learning and facial expression recognition in schizophrenic patients: Effects of social presence" and "Does cannabis affect cognitive functioning in patients with schizophrenia?".Schizophr Res Cogn. 2024 Feb 21;36:100303. doi: 10.1016/j.scog.2024.100303. eCollection 2024 Jun. Schizophr Res Cogn. 2024. PMID: 38414561 Free PMC article. No abstract available.
References
LinkOut - more resources
Full Text Sources